Retatrutide – 20mg (3 Pack)

Retatrutide is a novel triple-agonist peptide that engages GLP-1, GIP,
and glucagon receptors simultaneously. This multi-receptor activity has made it
a leading compound in obesity and metabolic research.
The 3 pack of 20mg vials delivers a total of 60mg, making it suitable for
extended or large-scale laboratory investigations.

Potential Research Benefits

• Studied for weight loss & appetite regulation
• Explored for glucose metabolism & insulin sensitivity
• Supports lipid regulation & energy balance
• Triple receptor engagement: GLP-1, GIP & glucagon

Scientific Background

Retatrutide’s triple-agonist action sets it apart from dual incretin compounds.
By engaging GLP-1, GIP, and glucagon receptors, it has demonstrated strong potential
in studies of weight regulation, glucose control, and energy metabolism.
Its unique mechanism has made it one of the most promising investigational
peptides in modern metabolic research.

Product Details

• Compound: Retatrutide
• Form: Lyophilized Powder
• Amount: 20mg per vial
• Pack Size: 3 vials (20mg each)
• Total Peptide: 60mg
• Purity: ≥99%
• Appearance: White to off-white powder
• Research Use Only: Not for human consumption